Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
Background: The incidence rate of uveitis in secukinumab-treated patients with axial spondyloarthritis (axSpA) was previously reported. Objective: To evaluate the incidence rate of uveitis in patients with axSpA and psoriatic arthritis (PsA) treated with secukinumab or placebo during placebo-control...
Saved in:
| Main Authors: | Jan Brandt-Jürgens, Martin Rudwaleit, Frank Behrens, Christopher Ritchlin, Daniel Peterlik, Erhard Quebe-Fehling, Atul Deodhar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Musculoskeletal Disease |
| Online Access: | https://doi.org/10.1177/1759720X251340255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
by: Stefano Gentileschi, et al.
Published: (2020-01-01) -
Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01) -
Effectiveness and safety of secukinumab in axial spondyloarthritis and psoriatic arthritis: A retrospective analysis of its real-world usage from India
by: Sham Santhanam, et al.
Published: (2020-01-01) -
Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: Е. Е. Gubar, et al.
Published: (2024-04-01) -
Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)